TUNE IN: This evening (May 10) the day after The Creative Coalition’s #RightToBearArts Advocacy Day on Capitol Hill and gala, Tim Daly (Madam Secretary, The Creative Coalition President) will have an appearance on MSNBC’s Meet the Press Daily, with guest host Hallie Jackson.
5:45 pm EDT – Meet the Press Daily with Chuck Todd (MSNBC)
Actor Tim Daly (The Creative Coalition President) will discuss the #RightToBearArts gala and his advocacy in Washington, DC for the National Endowment for the Arts with Optune and The Creative Coalition.
Please tune in this afternoon to hear more from Tim on his last few days in DC, joined by a celebrity delegation and Optune, advocating for the arts, art education, and the critical need to ensure greater federal funding for arts programs.
ABOUT THE CREATIVE COALITION: The Creative Coalition (www.TheCreativeCoalition.org) is the premier nonprofit, 501(c)(3) nonpartisan charity of the entertainment industry dedicated to using the power and platform of the arts and entertainment communities in award-winning public service and advocacy campaigns. Founded in 1989 by prominent members of the creative community, The Creative Coalition is dedicated to educating, mobilizing, and activating its members on issues of public importance. Actor Tim Daly serves as the organization’s president.
ABOUT THE #RIGHTTOBEARARTS GALA: The Creative Coalition’s annual gala brings together Hollywood stars, Members of Congress, and D.C. power players for an incredible evening that celebrates bipartisan support for arts inclusivity – and the vital role that art plays within our communities and our culture for all. The centerpiece of the evening will feature artists who are living with a rare and aggressive form of brain cancer all of whom are wearing Optune, a portable device to treat their cancer, and are able to continue to put their “life on play” with their artistic endeavors. The #RightToBearArts dinner and fashion show will follow a day of advocacy on Capitol Hill, where The Creative Coalition celebrity ambassadors will call on national lawmakers to continue federal funding of the National Endowment for the Arts. Leading into the gala that evening, they will be discussing the critical importance of arts inclusivity, equity and access.
ABOUT NOVOCURE: Novocure is a global oncology company developing a proprietary platform technology called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in multiple solid tumor types.